Literature DB >> 1837627

Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale.

A G Stewart1, P A Bardsley, S V Baudouin, J C Waterhouse, J S Thompson, A H Morice, P Howard.   

Abstract

BACKGROUND: The pathogenesis of oedema in hypoxic cor pulmonale is poorly understood. One possibility is a failure of atrial natriuretic peptide release, leading to salt and water retention. This hypothesis was tested by observing the response to an intravenous saline challenge in patients with and without cor pulmonale.
METHODS: Plasma atrial natriuretic peptide concentrations were measured before and for three hours after an intravenous saline load (0.1 ml 2.7% saline/kg/min for 60 minutes) in 20 patients with chronic obstructive airways disease. Ten patients with cor pulmonale, as judged clinically by the presence of peripheral oedema with a previously documented increase in the jugular venous pressure or pleural effusions during an acute exacerbation of airway obstruction (mean (SE) age 67 (3) years, FEV1 0.73 (0.08) 1, arterial oxygen tension (PaO2) 6.4 (0.4) kPa, and arterial carbon dioxide tension (PaCO2) 6.7 (0.3) kPa), were compared with 10 patients with hypoxic chronic obstructive airways disease who had never had oedema (mean age 63 (1) years, FEV1 1.07 (0.09) 1, PaO2 8.6 (0.4) kPa, and PaCO2 5.3 (0.2) kPa). All patients were studied fasting and after diuretics had been stopped for three days. No supplemental oxygen was given.
RESULTS: The mean four hourly urine sodium excretion was less in the patients who had oedema (27 (4.6) mmol, 13% of the intravenous load) than in those without oedema (82 (15.5) mmol, 43% of the load). Initial mean plasma atrial natriuretic peptide values were significantly higher in the patients with cor pulmonale (19.1 (1.6) compared with 10.2 (0.7) pmol/l) and the mean peak rise in atrial natriuretic peptide after the intravenous saline load had been given was 13 (8.0) pmol/l in the patients with cor pulmonale and 5.5 (2.3) pmol/l in the controls. There were no significant differences in plasma and urinary osmolality, blood pressure, or creatinine clearance between the groups.
CONCLUSION: Patients with chronic obstructive airways disease and cor pulmonale have an impaired ability to excrete a hypertonic intravenous saline load despite a normal physiological release of plasma atrial natriuretic peptide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837627      PMCID: PMC1021038          DOI: 10.1136/thx.46.11.829

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  AN EXPLANATION FOR ABNORMAL WATER RETENTION AND HYPOOSMOLALITY IN CONGESTIVE HEART FAILURE.

Authors:  N H BELL; H P SCHEDL; F C BARTTER
Journal:  Am J Med       Date:  1964-03       Impact factor: 4.965

2.  A study of cor pulmonale in patients with chronic bronchitis.

Authors:  M M PLATTS; J D HAMMOND; C H STUART-HARRIS
Journal:  Q J Med       Date:  1960-10

3.  An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.

Authors:  H P SCHEDL; F C BARTTER
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

4.  The renal circulation in chronic pulmonary disease and pulmonary heart failure.

Authors:  J D HAMMOND; J MACKINNON; W D SMITH; C H STUART-HARRIS
Journal:  Q J Med       Date:  1956-07

5.  Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.

Authors:  M E Brier; R A Brier; F C Luft; G R Aronoff
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

6.  Impaired water handling in chronic obstructive airways disease.

Authors:  R J White; D F Woodings
Journal:  Br Med J       Date:  1971-06-05

7.  Low dose infusion of atrial natriuretic peptide causes salt and water excretion in normal man.

Authors:  A Morice; J Pepke-Zaba; E Loysen; R Lapworth; M Ashby; T Higenbottam; M Brown
Journal:  Clin Sci (Lond)       Date:  1988-04       Impact factor: 6.124

8.  Atrial natriuretic peptide in primary pulmonary hypertension.

Authors:  A H Morice; J Pepke-Zaba; M J Brown; P S Thomas; T W Higenbottam
Journal:  Eur Respir J       Date:  1990-09       Impact factor: 16.671

9.  Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma.

Authors:  G A Sagnella; N D Markandu; A C Shore; G A MacGregor
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

10.  Atrial natriuretic factor does not inhibit basal or angiotensin II-stimulated proximal transport.

Authors:  F Y Liu; M G Cogan
Journal:  Am J Physiol       Date:  1988-09
View more
  5 in total

1.  Microalbuminuria in chronic obstructive lung disease.

Authors:  R Wilkinson; J S Milledge; M J Landon
Journal:  BMJ       Date:  1993-07-24

2.  Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease.

Authors:  T K Rogers; W Sheedy; J Waterhouse; P Howard; A H Morice
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

3.  Effects of angiotensin converting enzyme inhibition on sodium excretion in patients with hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P Baylis; P Howard
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

4.  Hormonal, renal, and autonomic nerve factors involved in the excretion of sodium and water during dynamic salt and water loading in hypoxaemic chronic obstructive pulmonary disease.

Authors:  A G Stewart; J C Waterhouse; C G Billings; P H Baylis; P Howard
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

5.  Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.

Authors:  J S Thompson; W Sheedy; A H Morice
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.